OBJECTIVES: To assess the acute effects of nicotine-containing electronic cigarettes versus tobacco smoking on vascular and respiratory function and circulating microparticles, particularly platelet microparticles (PMPs, biomarker of haemostasis/thrombosis) and endothelial microparticles (EMPs, biomarker of endothelial function). METHODS: Heart rate (HR), blood pressure, reactive hyperaemia index (RHI, microvascular reactivity), augmentation index (arterial stiffness) and respiratory function were assessed in 20 smokers immediately before and after electronic cigarettes use and tobacco smoking. The number of microparticles was determined by flow cytometry using counting beads as a reference. Labelling with Annexin-V was used to detect the total microparticle fraction. EMPs were characterized as CD31+CD42- and PMPs as CD31+CD42+. RESULTS: HR increased after electronic cigarettes use and tobacco smoking (P < 0.001), whereas blood pressure remained unchanged (P > 0.05). RHI (P = 0.006), augmentation index (P = 0.010) but not augmentation index standardized to HR 75 bpm (P > 0.05) increased with electronic cigarettes use but not with tobacco smoking. Following tobacco smoking, there was a significant increase in total microparticles (P < 0.001), EMPs (P < 0.001) and PMPs (P < 0.001). In contrast, electronic cigarettes were only associated with an increase in PMPs (P < 0.001), with no significant changes in the total microparticle fraction or EMPs (all P > 0.05). Peak expiratory flow significantly decreased following electronic cigarettes use (P = 0.019). CONCLUSION: Our results demonstrate that acute exposure to tobacco smoking as well as electronic cigarettes influences vascular and respiratory function. Where tobacco smoking significantly increased microparticle formation, indicative of possible endothelial injury, electronic cigarettes use induced vasoreactivity and decreased peak expiratory flow. These findings suggest that both electronic cigarettes and tobacco smoking negatively impact vascular function.
OBJECTIVES: To assess the acute effects of nicotine-containing electronic cigarettes versus tobacco smoking on vascular and respiratory function and circulating microparticles, particularly platelet microparticles (PMPs, biomarker of haemostasis/thrombosis) and endothelial microparticles (EMPs, biomarker of endothelial function). METHODS: Heart rate (HR), blood pressure, reactive hyperaemia index (RHI, microvascular reactivity), augmentation index (arterial stiffness) and respiratory function were assessed in 20 smokers immediately before and after electronic cigarettes use and tobacco smoking. The number of microparticles was determined by flow cytometry using counting beads as a reference. Labelling with Annexin-V was used to detect the total microparticle fraction. EMPs were characterized as CD31+CD42- and PMPs as CD31+CD42+. RESULTS: HR increased after electronic cigarettes use and tobacco smoking (P < 0.001), whereas blood pressure remained unchanged (P > 0.05). RHI (P = 0.006), augmentation index (P = 0.010) but not augmentation index standardized to HR 75 bpm (P > 0.05) increased with electronic cigarettes use but not with tobacco smoking. Following tobacco smoking, there was a significant increase in total microparticles (P < 0.001), EMPs (P < 0.001) and PMPs (P < 0.001). In contrast, electronic cigarettes were only associated with an increase in PMPs (P < 0.001), with no significant changes in the total microparticle fraction or EMPs (all P > 0.05). Peak expiratory flow significantly decreased following electronic cigarettes use (P = 0.019). CONCLUSION: Our results demonstrate that acute exposure to tobacco smoking as well as electronic cigarettes influences vascular and respiratory function. Where tobacco smoking significantly increased microparticle formation, indicative of possible endothelial injury, electronic cigarettes use induced vasoreactivity and decreased peak expiratory flow. These findings suggest that both electronic cigarettes and tobacco smoking negatively impact vascular function.
Authors: Terry Gordon; Emma Karey; Meghan E Rebuli; Yael-Natalie H Escobar; Ilona Jaspers; Lung Chi Chen Journal: Annu Rev Pharmacol Toxicol Date: 2021-09-23 Impact factor: 16.459
Authors: Amber Mills; Duaa Dakhlallah; Madison Robinson; Ally Kirk; Sam Llavina; Jonathan W Boyd; Paul D Chantler; I Mark Olfert Journal: Exp Physiol Date: 2022-06-17 Impact factor: 2.858
Authors: Robert Tarran; R Graham Barr; Neal L Benowitz; Aruni Bhatnagar; Hong W Chu; Pamela Dalton; Claire M Doerschuk; M Bradley Drummond; Diane R Gold; Maciej L Goniewicz; Eric R Gross; Nadia N Hansel; Philip K Hopke; Robert A Kloner; Vladimir B Mikheev; Evan W Neczypor; Kent E Pinkerton; Lisa Postow; Irfan Rahman; Jonathan M Samet; Matthias Salathe; Catherine M Stoney; Philip S Tsao; Rachel Widome; Tian Xia; DaLiao Xiao; Loren E Wold Journal: Function (Oxf) Date: 2021-02-08
Authors: Mario F Perez; Erin L Mead; Nkiruka C Atuegwu; Eric M Mortensen; Maciej Goniewicz; Cheryl Oncken Journal: J Womens Health (Larchmt) Date: 2021-02-02 Impact factor: 2.681
Authors: Loren E Wold; Robert Tarran; Evan W Neczypor; Matthew J Mears; Arunava Ghosh; M Flori Sassano; Richard J Gumina Journal: Circulation Date: 2022-01-18 Impact factor: 29.690
Authors: E N Burrage; E Aboaziza; L Hare; S Reppert; J Moore; W T Goldsmith; E E Kelley; A Mills; D Dakhlallah; P D Chantler; I M Olfert Journal: Am J Physiol Heart Circ Physiol Date: 2021-06-25 Impact factor: 5.125